News & Events
Contact

Day: May 19, 2026

GRIPonMASH Reaches Major Milestone: Over 5,000 Participants Enrolled and 25,000+ Samples Collected Across Europe 

Graphic announcing that the GRIPonMASH project has reached more than 5,000 participants enrolled across Europe. The visual highlights the project’s work on improving early detection of liver disease in at-risk populations and includes GRIPonMASH branding and logo.

European study reaches halfway point of ambitious goal of screening 10,000 individuals at risk of MASLD Utrecht, The Netherlands, May 19, 2026: The GRIPonMASH project has reached a significant milestone in its mission to improve early detection and understanding of metabolic dysfunction-associated steatotic liver disease (MASLD). More than 5,000 participants, representing over 50% of the […]

This project is supported by the Innovative Health Initiative Joint Undertaking (IHI JU) under grant agreement No 101132946. The JU receives support from the European Union’s Horizon Europe research and innovation programme and COCIR, Efpia, EuropaBio, MedTech Europe, Vaccines Europe and Mercodia Aktiebolag, Metadeq Limited and Julius Clinical Research BV.

Funded by the European Union, the private members, and those contributing partners of the IHI JU. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the aforementioned parties. Neither of the aforementioned parties can be held responsible for them.

News & events
Contact
Linkedin
Linkedin
Contact
Press release
Copyright © 2024 GRIPonMASH. All Rights Reserved.

Privacy policy   Cookie statement